Adverts

Open Access Articles- Top Results for Arbaclofen placarbil

Arbaclofen placarbil

</th></tr>
Arbaclofen placarbil
260px
Systematic (IUPAC) name
(3R)-3-(4-chlorophenyl)-4-[[[(1S)-2-methyl-1-[(2-methylpropanoyl)oxy]propoxy]carbonyl]amino]butanoic acid
Clinical data
  • N/A
  • Development terminated
Identifiers
847353-30-4
None
PubChem CID 11281011
ChemSpider 9456008
KEGG D08861 7pxY
ChEMBL CHEMBL2107312 7pxY
Chemical data
Formula C19H26ClNO6
399.86 g/mol

Arbaclofen placarbil (ar-BAC-loe-fen pla-KAR-bil, also known as XP19986) is a prodrug of R-baclofen. Arbaclofen placarbil possesses more favorable pharmacokinetic profile than baclofen, with less fluctuations in plasma drug levels. It was being developed as a potential treatment for patients with GERD and spasticity due to multiple sclerosis; however, in May 2013 XenoPort announced the termination of development because of unsuccessful results in phase III clinical trials.[1]

See also

References



Lua error in package.lua at line 80: module 'Module:Buffer' not found. Lua error in package.lua at line 80: module 'Module:Buffer' not found.